NEW YORK (GenomeWeb) – PerkinElmer announced that it has priced an offering of €500 million ($554.2 million) of 1.875 percent senior notes due 2026 at an issue price of 99.118 percent of the principal amount.

The issuance is expected to close on July 19, the company said, and the notes will pay interest on an annual basis.

PerkinElmer plans to use the proceeds to reduce the amounts outstanding under its senior unsecured revolving credit facility and for general corporate purposes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.